Advanced/ metastatic HER-2 positive breast cancer

Clinical trials for Advanced/ metastatic HER-2 positive breast cancer explained in plain language.

Never miss a new study

Get alerted when new Advanced/ metastatic HER-2 positive breast cancer trials appear

Sign up with your email to follow new studies for Advanced/ metastatic HER-2 positive breast cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a Two-Drug attack outsmart resistant breast cancer?

Disease control Recruiting now

This trial is testing whether a new antibody-drug conjugate called GQ1001, when combined with the oral drug pyrotinib, can safely shrink tumors in people with HER2-positive metastatic breast cancer that has stopped responding to earlier anti-HER2 treatments. The study enrolls abo…

Matched conditions: ADVANCED/ METASTATIC HER-2 POSITIVE BREAST CANCER

Phase 1/2 • Sponsor: Fudan University • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC

Advanced/ metastatic HER-2 positive breast cancer

Get alerted when new Advanced/ metastatic HER-2 positive breast cancer trials appear

Can a Two-Drug attack outsmart resistant breast cancer?